Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ikena Oncology Inc
(NQ:
IKNA
)
1.750
+0.030 (+1.74%)
Streaming Delayed Price
Updated: 9:31 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ikena Oncology Inc
< Previous
1
2
3
4
5
Next >
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology to Present at Multiple November 2023 Investor Conferences
November 07, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Optimism Surrounds Cancer Focused Ikena Oncology, Analyst Initiates With Outperform
September 22, 2023
Ikena Oncology Inc (NASDAQ: IKNA) is garnering attention with its oncology-focused pipeline, and the company's recent developments have raised optimism in the medical community.
Via
Benzinga
Ikena Oncology to Participate in September 2023 Investor Conferences
September 05, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Analyst Ratings for Ikena Oncology
May 16, 2023
Via
Benzinga
Credit Suisse Maintains Outperform Rating for Ikena Oncology: Here's What You Need To Know
March 15, 2023
Via
Benzinga
Ikena Oncology Earnings Perspective: Return On Capital Employed
March 15, 2023
Via
Benzinga
Ikena Oncology's Return On Capital Employed Insights
November 30, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
September 22, 2023
Via
Benzinga
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update
August 10, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 08, 2023
We're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday!
Via
InvestorPlace
Ikena Oncology Acquires Pionyr Immunotherapeutics: Analysts See The Deal As Positive Move
August 07, 2023
Ikena Oncology Inc (NASDAQ: IKNA) acquired Pionyr Immunotherapeutics Inc, a privately-held biotechnology company, in
Via
Benzinga
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
August 07, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology to Participate in Upcoming Investor Conferences
May 24, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology Pipeline
May 15, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Announces $40 Million Underwritten Offering
May 15, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology to Participate in the Stifel 2023 Virtual Targeted Oncology Days
April 20, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Shares Differentiation Profile of IK-930, a Novel Hippo-Pathway Inhibitor, Including Projected Therapeutic Index Advantages and Breadth of Patient Populations at AACR 2023 Annual Meeting
April 17, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Reports Fourth Quarter and Full Year 2022 Financial Results
March 14, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Presents Preclinical Data on IK-595, Best-in-Class Next-Generation MEK-RAF Complex Inhibitor, in Plenary Session at AACR Special Conference on RAS Targeting
March 07, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Receives FDA Fast Track Designation for Novel AHR Antagonist IK-175 in Combination with Nivolumab to Treat Urothelial Carcinoma
March 06, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology to Participate in Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Ikena Oncology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 27, 2022
Via
Benzinga
Ikena Oncology Appoints Owen Hughes as Board Chair
December 19, 2022
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
December 09, 2022
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
Via
Benzinga
Ikena Oncology Announces New Cancer Program, Shelves Early Asset For Colorectal Cancer
November 28, 2022
Ikena Oncology Inc (NASDAQ: IKNA) nominated a next-generation mitogen-activated protein kinase (MEK)-RAF complex inhibitor, IK-595, as its first development candidate in the RAS pathway.
Via
Benzinga
Ikena Oncology Announces New Program in Next-Generation MEK-RAF Inhibition and Provides Corporate Update
November 28, 2022
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology to Participate in the Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Announces Initial Clinical Data from IK-175 Program in Urothelial Carcinoma
November 10, 2022
From
Ikena Oncology, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.